![]() |
|
|
Vol. 282, Issue 1, 228-235, 1997
Synthélabo Recherche, Department of Internal Medicine, 10 rue des
Carrières, 92504 Rueil-Malmaison, France
We investigated the relevance of selectivity for a given
alpha-1-adrenoceptor subtype for in vivo
uroselectivity of several alpha-1-adrenoceptor antagonists
(alfuzosin, doxazosin, prazosin, tamsulosin, terazosin and
5-Me-urapidil). Comparison of the affinities of these
alpha-1-adrenoceptor antagonists at the cloned
alpha-1a, alpha-1b and
alpha-1d-adrenoceptor subtypes revealed that tamsulosin and
5-Me-urapidil showed selectivity for the alpha-1a subtype. No significant correlations were found between the affinities for
alpha-1b or alpha-1d-adrenoceptors and the
pKB values obtained against
phenylephrine-induced contraction of the rabbit prostate in
vitro. In contrast, the antagonist potencies in rabbit prostate were correlated (r = 0.89, P < .05) with the
pKi values for the alpha-1a-adrenoceptor subtype. However, the
pKB values were consistently smaller (by 0.6 to
1.9 log unit) than the pKi values for the
alpha-1a-adrenoceptor subtype, a result that suggests that
the alpha-1-adrenoceptor mediating urethral contractions
does not have all the characteristics of the
alpha-1a-adrenoceptor. The simultaneous measurement of urethral and arterial pressures in the same conscious male rat allows
evaluation of the functional uroselectivity of these antagonists based
on their respective effects on both pressures. Dose ranges were
selected according to effects on urethral pressure and most antagonists
were found effective within the 3 to 100 µg/kg i.v. range. Alfuzosin
markedly decreased urethral pressure and either did not decrease blood
pressure (10-30 µg/kg) or slightly decreased it at the highest dose
tested (100 µg/kg). Doxazosin did not produce sustained reductions in
urethral pressure until a dose of 30 µg/kg. Blood pressure was not
reduced until 100 µg/kg. Prazosin reduced urethral pressure and blood
pressure within the same dose-range whereas terazosin did not decrease
urethral pressure at doses that significantly decreased blood pressure
(30 and 100 µg/kg). 5-Me-urapidil, an alpha-1a-selective
compound did not significantly modify urethral and blood pressure
whereas tamsulosin, another alpha-1a-selective compound
reduced urethral pressure and blood pressure within the same dose
range. In conclusion, in the conscious male rat the functional
uroselectivity is not correlated with a selective affinity for the
alpha-1a-adrenoceptor subtype.
This article has been cited by other articles:
![]() |
A. A. Hancock, S. A. Buckner, M. E. Brune, T. A. Esbenshade, L. M. Ireland, S. Katwala, I. Milicic, M. D. Meyer, J. F. Kerwin Jr., and M. Williams Preclinical Pharmacology of Fiduxosin, a Novel alpha 1-Adrenoceptor Antagonist with Uroselective Properties J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 478 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamada, T. Okura, R. Kimura, Y. Deguchi, Y. Suzuki, T. Kobayashi, and K. Aisaka Disposition and alpha 1-Adrenoceptor Binding Characteristics of JTH-601 and Its Metabolites in Rat Tissues Drug Metab. Dispos., April 13, 2001; 28(12): 1487 - 1492. [Abstract] [Full Text] |
||||
![]() |
S. Yamada, T. Okura, and R. Kimura In Vivo Demonstration of {alpha}1A-Adrenoceptor Subtype Selectivity of KMD-3213 in Rat Tissues J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 160 - 167. [Abstract] [Full Text] |
||||
![]() |
V. L. Pulito, X. Li, S. S. Varga, L. S. Mulcahy, K. S. Clark, S. A. Halbert, A. B. Reitz, W. V. Murray, and L. K. Jolliffe An Investigation of the Uroselective Properties of Four Novel alpha 1a-Adrenergic Receptor Subtype-Selective Antagonists J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 224 - 229. [Abstract] [Full Text] |
||||
![]() |
Y. Fukuta, Y. Fukuda, R. Higashino, K. Yoshida, M. Ogishima, H. Tamaki, and M. Takei Z-350, A Novel Compound with alpha 1-Adrenoceptor Antagonistic and Steroid 5alpha -Reductase Inhibitory Actions: Pharmacological Properties In Vivo J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1013 - 1018. [Abstract] [Full Text] |
||||
![]() |
S. Yamada, T. Ohkura, Y. Deguchi, and R. Kimura In Vivo Measurement by [3H]Tamsulosin of alpha 1 Adrenoceptors in Rat Tissues in Relation to the Pharmacokinetics J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1575 - 1583. [Abstract] [Full Text] |
||||